James J. Hsieh, MD, PhD, Memorial Sloan Kettering Cancer Center presents Differential Overall Survival Results in RECORD-3 Study Based on Three Distinct Clear Cell Metastatic Renal Cell Carcinoma Molecular Subgroups Classified by BAP1 and/or PBRM1 Mutations at the 2016 annual International Kidney Cancer Symposium.
Differential Overall Survival Results in RECORD-3 Study Based on Three Distinct Clear Cell Metastatic Renal Cell Carcinoma Molecular Subgroups Classified by BAP1 and/or PBRM1 Mutations
